Kavita Nair, PhD, discusses how clinicians select MS therapies, the role of cost and access, and why policy changes could threaten patient outcomes. The treatment landscape for multiple sclerosis (MS) ...

If the suit is successful, the developer could escape those repair bills, demolish the tower and build its planned luxury condos. Anyone can view a sampling of recent comments, but you must be a Times ...